|
|
|
|
| LEADER |
00000cam a22000004i 4500 |
| 001 |
1028029 |
| 003 |
FI-J |
| 005 |
20210226153420.0 |
| 006 |
m||||||||d|||||||| |
| 007 |
cu|||||||||a|| |
| 008 |
070515s2007 fi |||||sm |||||||eng|| |
| 035 |
|
|
|a 1028029
|
| 041 |
0 |
|
|a eng
|b fin
|
| 100 |
1 |
|
|a Ollila, Hanna.
|
| 245 |
1 |
0 |
|a VEGF-B as a target for cancer therapy :
|b characterization of monoclonal antibodies towards VEGF-B and generation of VEGF-B expressing tumour cell lines /
|c Hanna Ollila.
|
| 260 |
|
|
|a Jyväskylä,
|c 2007.
|
| 300 |
|
|
|a 56 sivua
|
| 336 |
|
|
|a teksti
|b txt
|2 rdacontent
|
| 337 |
|
|
|a tietokonekäyttöinen
|b c
|2 rdamedia
|
| 338 |
|
|
|a verkkoaineisto
|b cr
|2 rdacarrier
|
| 509 |
|
|
|a Pro gradu -työ :
|c Jyväskylän yliopisto, bio- ja ympäristötieteiden laitos, solubiologia.
|9 4013.
|
| 579 |
|
|
|a XLUETTELOITU
|
| 650 |
|
7 |
|a syöpätaudit
|2 yso/fin
|0 http://www.yso.fi/onto/yso/p678
|
| 650 |
|
7 |
|a vasta-aineet
|2 yso/fin
|0 http://www.yso.fi/onto/yso/p12206
|
| 653 |
|
|
|a Vascular Endothelial Growth Factor B
|
| 653 |
|
|
|a VEGF-B
|
| 653 |
|
|
|a tumour angiogenesis
|
| 653 |
|
|
|a monoclonal antibody therapy
|
| 856 |
4 |
0 |
|u http://urn.fi/URN:NBN:fi:jyu-2007317
|u URN:NBN:fi:jyu-2007317
|
| 999 |
|
|
|c 1028029
|d 1028029
|